Tondabayashi, Japan

Eiko Imamiya

This inventor holds 4 USPTO granted patents. Top assignees: Takeda Chemical Industries, Inc., Takeda Chemical Company, Ltd.. Active years: 1978-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eiko Imamiya. Retrieved from https://idiyas.com/inventor/eiko-imamiya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 18(Granted Patents)


Location History:

  • Tondabayashi, JA (1978)
  • Osaka, JP (1990 - 1992)

Company Filing History:


Years Active: 1978-1992

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Eiko Imamiya: Pioneering Female Inventor from Tondabayashi

Introduction: Eiko Imamiya is a trailblazing inventor hailing from Tondabayashi, Japan, known for her innovative contributions to various fields.

Latest Patents: Eiko Imamiya holds several patents in the areas of sustainable energy solutions and advanced medical devices, showcasing her versatility and forward-thinking approach.

Career Highlights: Throughout her illustrious career, Eiko Imamiya has been recognized for her groundbreaking inventions that have significantly impacted industries such as technology, healthcare, and environmental sustainability.

Collaborations: Eiko Imamiya has collaborated with leading research institutions and universities worldwide, fostering a culture of innovation and knowledge exchange to drive progress in her areas of expertise.

Conclusion: Eiko Imamiya's dedication to pushing the boundaries of innovation and her commitment to creating a better future through her inventions solidify her legacy as a pioneering female inventor in Tondabayashi and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…